StromaCare, a French biotechnology company pioneering the discovery and development of cancer immunotherapies through stroma modulation, has appointed Georges Rawadi as chief executive officer (CEO).   Rawadi’s objectives include raising funds and building partnerships to support StromaCare’s lead product development towards clinical trials and continuing to develop the pipeline.   “I am very enthusiastic about Georges joining StromaCare as CEO,” said Philippe Archinard, president of the str...